CD19+ B cells in the TME of pure thymoma were few and diffusely distributed, whereas CD19+ B cells in the TME of TMG patients were generally aggregated and participated in the formation of GCs, as well as being distributed in the PVS. This evidence concerns the gene CD19 and thymoma.